Page last updated: 2024-10-28

hexamethylene bisacetamide and Cancer of Mouth

hexamethylene bisacetamide has been researched along with Cancer of Mouth in 2 studies

N,N'-diacetyl-1,6-diaminohexane: chemical name obtained from Acta Biol Hung 1990;41(1-3):199-208

Research Excerpts

ExcerptRelevanceReference
"Hexamethylene bisacetamide treatment promoted the cytopathic effect of R849 and increased the proportion of dead cells."1.33Enhancement of antitumor activity of herpes simplex virus gamma(1)34.5-deficient mutant for oral squamous cell carcinoma cells by hexamethylene bisacetamide. ( Ikuta, K; Iwai, S; Naito, S; Nakazawa, M; Obayashi, S; Sumi, T; Yura, Y, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Naito, S1
Obayashi, S1
Sumi, T1
Iwai, S1
Nakazawa, M1
Ikuta, K1
Yura, Y2
Tsujimoto, H1
Kusaka, J1
Yoshida, H1
Sato, M1

Other Studies

2 other studies available for hexamethylene bisacetamide and Cancer of Mouth

ArticleYear
Enhancement of antitumor activity of herpes simplex virus gamma(1)34.5-deficient mutant for oral squamous cell carcinoma cells by hexamethylene bisacetamide.
    Cancer gene therapy, 2006, Volume: 13, Issue:8

    Topics: Acetamides; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; F

2006
Hexamethylene bisacetamide as a chemopreventive agent in hamster cheek pouch tumorigenesis.
    European journal of cancer. Part B, Oral oncology, 1996, Volume: 32B, Issue:4

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Acetamides; Administration, Oral; Animals; Antineoplastic Agents;

1996